Karl C. Kuban, MD

Emeritus Professor, Pediatrics

Karl Kuban


Karl Kuban brings depth and breadth in clinical care, research and teaching to his role as Chief of the Pediatric Neurology Division at Boston Medical Center. Dr. Kuban was resident training coordinator in Pediatric Neurology at both Children’s Hospital Boston, where he was on staff for 16 years, and at Tufts-New England Medical Center, where he was Associate Chief for 8 years. He has authored more than 70 original peer-reviewed publications, has created an interactive training CD/video for conducting a pediatric neurological examination, and has received awards for teaching and patient care.

Dr. Kuban completed his pediatrics training at Children’s Hospital Boston and his neurology training in the Longwood Area/Children’s Hospital Neurological Training Program. Dr. Kuban obtained a master’s degree in epidemiology from the Harvard School of Public Health and he has had a broad range of research interests, including ones focused on neonatal neurology, cerebral palsy, childhood stroke, autism and brain injury related to congenital heart disease. He currently serves as co-principal investigator for a multi-center NIH study looking at biological markers in the bloods of babies born under 28 weeks gestation.

Other Positions

  • Emeritus Professor, Neurology, Boston University Chobanian & Avedisian School of Medicine
  • Boston Medical Center


  • University of Miami, MD
  • Ohio State University, BSc
  • Harvard School of Public Health, SM/ScM


  • Published on 7/14/2022

    Wu YW, Comstock BA, Gonzalez FF, Mayock DE, Goodman AM, Maitre NL, Chang T, Van Meurs KP, Lampland AL, Bendel-Stenzel E, Mathur AM, Wu TW, Riley D, Mietzsch U, Chalak L, Flibotte J, Weitkamp JH, Ahmad KA, Yanowitz TD, Baserga M, Poindexter BB, Rogers EE, Lowe JR, Kuban KCK, O'Shea TM, Wisnowski JL, McKinstry RC, Bluml S, Bonifacio S, Benninger KL, Rao R, Smyser CD, Sokol GM, Merhar S, Schreiber MD, Glass HC, Heagerty PJ, Juul SE. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. N Engl J Med. 2022 07 14; 387(2):148-159. PMID: 35830641.

    Read at: PubMed
  • Published on 6/28/2022

    Eaves LA, Enggasser AE, Camerota M, Gogcu S, Gower WA, Hartwell H, Jackson WM, Jensen E, Joseph RM, Marsit CJ, Roell K, Santos HP, Shenberger JS, Smeester L, Yanni D, Kuban KCK, O'Shea TM, Fry RC. CpG methylation patterns in placenta and neonatal blood are differentially associated with neonatal inflammation. Pediatr Res. 2022 Jun 28. PMID: 35764815.

    Read at: PubMed
  • Published on 6/7/2022

    Torres AR, Mohanty M, Salvador C, Chavez W, Mora M, Kuban K. Professional and Demographic Profile of Spanish-Speaking Child Neurologists in the United States. J Child Neurol. 2022 Aug; 37(8-9):689-692. PMID: 35673712.

    Read at: PubMed
  • Published on 3/3/2022

    Liu W, Sun Q, Huang L, Bhattacharya A, Wang GW, Tan X, Kuban KCK, Joseph RM, O'Shea TM, Fry RC, Li Y, Santos HP. Innovative computational approaches shed light on genetic mechanisms underlying cognitive impairment among children born extremely preterm. J Neurodev Disord. 2022 03 03; 14(1):16. PMID: 35240980.

    Read at: PubMed
  • Published on 2/4/2022

    Bhattacharya A, Freedman AN, Avula V, Harris R, Liu W, Pan C, Lusis AJ, Joseph RM, Smeester L, Hartwell HJ, Kuban KCK, Marsit CJ, Li Y, O'Shea TM, Fry RC, Santos HP. Placental genomics mediates genetic associations with complex health traits and disease. Nat Commun. 2022 02 04; 13(1):706. PMID: 35121757.

    Read at: PubMed
  • Published on 12/29/2021

    Frazier JA, Cochran D, Kim S, Jalnapurkar I, Joseph RM, Hooper SR, Santos HP, Ru H, Venuti L, Singh R, Washburn LK, Gogcu S, Msall ME, Kuban KCK, Rollins JV, Hanson SG, Jara H, Pastyrnak SL, Roell KR, Fry RC, O'Shea TM. Psychiatric Outcomes, Functioning, and Participation in Extremely Low Gestational Age Newborns at Age 15 Years. J Am Acad Child Adolesc Psychiatry. 2022 Jul; 61(7):892-904.e2. PMID: 34973366.

    Read at: PubMed
  • Published on 10/4/2021

    Wood TR, Parikh P, Comstock BA, Law JB, Bammler TK, Kuban KC, Mayock DE, Heagerty PJ, Juul S. Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial. EBioMedicine. 2021 Oct; 72:103605. PMID: 34619638.

    Read at: PubMed
  • Published on 9/8/2021

    Belfort MB, Ramel SE, Martin CR, Fichorova R, Kuban KCK, Heeren T, Fry RC, O'Shea TM. Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age. J Pediatr. 2022 01; 240:37-43.e1. PMID: 34508750.

    Read at: PubMed
  • Published on 8/11/2021

    Kuban KCK, Boynton-Jarrett R, Heeren T, O'Shea TM. A Consideration of Racism in Pediatric Epidemiologic Studies. J Pediatr. 2021 12; 239:225-227. PMID: 34390694.

    Read at: PubMed
  • Published on 6/4/2021

    Campbell H, Check J, Kuban KCK, Leviton A, Joseph RM, Frazier JA, Douglass LM, Roell K, Allred EN, Fordham LA, Hooper SR, Jara H, Paneth N, Mokrova I, Ru H, Santos HP, Fry RC, O'Shea TM. Neonatal Cranial Ultrasound Findings among Infants Born Extremely Preterm: Associations with Neurodevelopmental Outcomes at 10 Years of Age. J Pediatr. 2021 10; 237:197-205.e4. PMID: 34090894.

    Read at: PubMed

View 210 more publications: View full profile at BUMC

View all profiles